Molecular subtypes of breast cancer in relation to paclitaxel response and outcomes in women with metastatic disease: results from CALGB 9342

INTRODUCTION: The response to paclitaxel varies widely in metastatic breast cancer. We analyzed data from CALGB 9342, which tested three doses of paclitaxel in women with advanced disease, to determine whether response and outcomes differed according to HER2, hormone receptor, and p53 status. METHOD...

Descripción completa

Detalles Bibliográficos
Autores principales: Harris, Lyndsay N, Broadwater, Gloria, Lin, Nancy U, Miron, Alexander, Schnitt, Stuart J, Cowan, David, Lara, Jonathan, Bleiweiss, Ira, Berry, Donald, Ellis, Matthew, Hayes, Daniel F, Winer, Eric P, Dressler, Lynn
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2006
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1797029/
https://www.ncbi.nlm.nih.gov/pubmed/17129383
http://dx.doi.org/10.1186/bcr1622

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1797029/
https://www.ncbi.nlm.nih.gov/pubmed/17129383
http://dx.doi.org/10.1186/bcr1622

Ejemplares similares